<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01041989</url>
  </required_header>
  <id_info>
    <org_study_id>THL/TUET 122/2009</org_study_id>
    <nct_id>NCT01041989</nct_id>
  </id_info>
  <brief_title>Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability</brief_title>
  <acronym>FINGER</acronym>
  <official_title>Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute for Health and Welfare, Finland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Academy of Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helsinki University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Eastern Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kuopio Research Institute of Exercise Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Western Ontario, Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Umeå University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute for Health and Welfare, Finland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multi-center (6 sites: Helsinki, Kuopio, Oulu, Seinäjoki, Turku, Vantaa) intervention
      study aims to prevent cognitive impairment, dementia and disability in 60-77 year old persons
      at an increased dementia risk. The 2-year multi-domain life-style intervention includes
      nutritional guidance, exercise, cognitive training, increased social activity, and intensive
      monitoring and management of metabolic and vascular risk factors. The primary outcome is
      cognitive impairment measured by a sensitive Neuropsychological Test Battery (NTB), and
      Stroop and Trail Making tests to capture early cognitive impairment typical for both
      Alzheimer's disease and vascular dementia. We hypothesize that the multi-domain intervention
      will reduce cognitive impairment in the study group compared to the control group during the
      initial 2-year intervention period and reduce dementia incidence after the 7-year extended
      follow-up.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cognitive impairment assessed with a Neuropsychological Test Battery, and Stroop and Trail Making tests.</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depressive symptoms will be assessed using the Zung depression scale.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disability will be assessed using the ADCS-ADL scale</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life will be assessed using the RAND-36 and 15D questionnaires.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Utilization of health resources will be assessed using questionnaire and register data.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular and metabolic risk factors will be assessed with blood pressure and anthropometric measurements, and laboratory analyses of metabolic biomarkers.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular and metabolic morbidity and mortality will be assessed through questionnaire and register data.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in dietary biomarker levels will be assessed through laboratory testing.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Cognitive Impairment</condition>
  <condition>Dementia</condition>
  <arm_group>
    <arm_group_label>Standard health counseling at baseline</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lifestyle counseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multi-domain lifestyle counseling including nutritional guidance, increased physical activity, cognitive training, increased social activity and intensive monitoring of vascular and metabolic risk factors.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nutritional guidance</intervention_name>
    <description>Individual counseling sessions and group meetings will be organized.</description>
    <arm_group_label>Lifestyle counseling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Guided muscle strength training and aerobic exercise.</description>
    <arm_group_label>Lifestyle counseling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive training</intervention_name>
    <description>Cognitive training will be implemented through 8 group sessions lead by a psychologist and a computer-based cognitive training program available to participants via the internet.</description>
    <arm_group_label>Lifestyle counseling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Reduction of vascular risk factors</intervention_name>
    <description>Monitoring and maintenance of metabolic and vascular risk factors</description>
    <arm_group_label>Lifestyle counseling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged 60-77 years

          -  dementia Risk Score 6 points or more

          -  fulfillment of at least one of the following CERAD criteria: i) MMSE: 20-26 points ii)
             word list memory task (3x10 words): 19 words or less iii) delayed recall: 75% or less

        Exclusion Criteria:

          -  malignant diseases

          -  dementia

          -  substantial cognitive decline

          -  major depression

          -  symptomatic cardiovascular disease

          -  revascularisation within 1 year

          -  severe loss of vision, hearing or communicative ability

          -  other conditions inhibiting from safe engagement in the prescribed intervention as
             judged by the study physician

          -  other conditions preventing from cooperation as judged by the study physician
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>77 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miia Kivipelto, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute for Health and Welfare, Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tiina K Laatikainen, professor</last_name>
    <role>Study Director</role>
    <affiliation>National Institute for Health and Welfare, Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hilkka S Soininen, professor</last_name>
    <role>Study Director</role>
    <affiliation>University of Eastern Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jaakko Tuomilehto, professor</last_name>
    <role>Study Director</role>
    <affiliation>Helsinki University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Timo E Strandberg, professor</last_name>
    <role>Study Director</role>
    <affiliation>University of Oulu</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raimo Sulkava, professor</last_name>
    <role>Study Director</role>
    <affiliation>University of Eastern Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rainer Rauramaa, professor</last_name>
    <role>Study Director</role>
    <affiliation>Kuopio Research Institute of Exercise Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antti Jula, research prof</last_name>
    <role>Study Director</role>
    <affiliation>National Institute for Health and Welfare, Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markku Peltonen, Adjunct prof</last_name>
    <role>Study Director</role>
    <affiliation>National Institute for Health and Welfare, Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Satu Pajala, PhD</last_name>
    <role>Study Director</role>
    <affiliation>National Institute for Health and Welfare, Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jaana Lindström, Adjunct prof.</last_name>
    <role>Study Director</role>
    <affiliation>National Institute for Health and Welfare, Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Riitta Antikainen, Adjunct prof</last_name>
    <role>Study Director</role>
    <affiliation>Oulu City Health Services</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tiia Ngandu, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>National Institute for Health and Welfare, Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tuomo Hänninen, Adjunct prof</last_name>
    <role>Study Director</role>
    <affiliation>University of Eastern Finland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institute for Health and Welfare</name>
      <address>
        <city>Helsinki</city>
        <zip>00300</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kuopio</name>
      <address>
        <city>Kuopio</city>
        <zip>70211</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Oulu</name>
      <address>
        <city>Oulu</city>
        <zip>90014</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Center Mediwest</name>
      <address>
        <city>Seinajoki</city>
        <zip>60220</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Institute for Health and Welfare</name>
      <address>
        <city>Turku</city>
        <zip>20720</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 2006 Sep;5(9):735-41.</citation>
    <PMID>16914401</PMID>
  </reference>
  <reference>
    <citation>Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001 Jun 16;322(7300):1447-51.</citation>
    <PMID>11408299</PMID>
  </reference>
  <reference>
    <citation>Kivipelto M, Helkala EL, Hänninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology. 2001 Jun 26;56(12):1683-9.</citation>
    <PMID>11425934</PMID>
  </reference>
  <reference>
    <citation>Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med. 2002 Aug 6;137(3):149-55.</citation>
    <PMID>12160362</PMID>
  </reference>
  <reference>
    <citation>Rovio S, Kåreholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J, Soininen H, Nissinen A, Kivipelto M. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol. 2005 Nov;4(11):705-11.</citation>
    <PMID>16239176</PMID>
  </reference>
  <reference>
    <citation>Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005 Oct;62(10):1556-60.</citation>
    <PMID>16216938</PMID>
  </reference>
  <reference>
    <citation>Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006 Nov 11;368(9548):1673-9.</citation>
    <PMID>17098085</PMID>
  </reference>
  <reference>
    <citation>Kivipelto M, Rovio S, Ngandu T, Kåreholt I, Eskelinen M, Winblad B, Hachinski V, Cedazo-Minguez A, Soininen H, Tuomilehto J, Nissinen A. Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study. J Cell Mol Med. 2008 Dec;12(6B):2762-71. doi: 10.1111/j.1582-4934.2008.00296.x. Epub 2008 Feb 8.</citation>
    <PMID>18318693</PMID>
  </reference>
  <results_reference>
    <citation>Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R, Bäckman L, Hänninen T, Jula A, Laatikainen T, Lindström J, Mangialasche F, Nissinen A, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement. 2013 Nov;9(6):657-65. doi: 10.1016/j.jalz.2012.09.012. Epub 2013 Jan 17.</citation>
    <PMID>23332672</PMID>
  </results_reference>
  <results_reference>
    <citation>Ngandu T, Lehtisalo J, Levälahti E, Laatikainen T, Lindström J, Peltonen M, Solomon A, Ahtiluoto S, Antikainen R, Hänninen T, Jula A, Mangialasche F, Paajanen T, Pajala S, Rauramaa R, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M. Recruitment and baseline characteristics of participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)-a randomized controlled lifestyle trial. Int J Environ Res Public Health. 2014 Sep 10;11(9):9345-60. doi: 10.3390/ijerph110909345.</citation>
    <PMID>25211775</PMID>
  </results_reference>
  <results_reference>
    <citation>Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, Bäckman L, Hänninen T, Jula A, Laatikainen T, Lindström J, Mangialasche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015 Jun 6;385(9984):2255-63. doi: 10.1016/S0140-6736(15)60461-5. Epub 2015 Mar 12.</citation>
    <PMID>25771249</PMID>
  </results_reference>
  <results_reference>
    <citation>Kulmala J, Ngandu T, Pajala S, Lehtisalo J, Levälahti E, Antikainen R, Laatikainen T, Oksa H, Peltonen M, Rauramaa R, Soininen H, Strandberg T, Tuomilehto J, Kivipelto M. Leisure-Time and Occupational Physical Activity in Early and Late Adulthood in Relation to Later Life Physical Functioning. J Phys Act Health. 2016 Oct;13(10):1079-1087. Epub 2016 Aug 16.</citation>
    <PMID>27254853</PMID>
  </results_reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2010</study_first_submitted>
  <study_first_submitted_qc>January 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2010</study_first_posted>
  <last_update_submitted>October 7, 2016</last_update_submitted>
  <last_update_submitted_qc>October 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Institute for Health and Welfare, Finland</investigator_affiliation>
    <investigator_full_name>Miia Kivipelto</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>dementia</keyword>
  <keyword>cognitive impairment</keyword>
  <keyword>disability</keyword>
  <keyword>intervention</keyword>
  <keyword>elderly</keyword>
  <keyword>lifestyle counseling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

